BICLUSTER_ID : UPREG-36
PATHOGENS /3/ : bifidobacterium bifidum,mycobacterium tuberculosis,ehrlichia chaffeensis
TARGETS /19/ : LCK, JUN, CCL2, TNFRSF1B, HCK, GLA, AMPD3, CCL5, CD86, STAT1, IL12B, HMOX1, HSPA1B, IL6, IL1B, PTGS2, CASP1, PTGER2, TNF
Gene SetLeading Edge Genes
NETPATH IL 2 PATHWAY UPPFKFB3, LCK, JUN, STAT4, TNFRSF1B, NMI, TRAFD1, IFI44, IER3, IFIT1, STAT1, SP100, TNFSF10, GADD45G, TRIM21, IL6, RGS1, IL1B, CASP1, IRF1, UPP1, TNF, MX1
NCI IL23PATHWAYSTAT1, IL6, IL12B, IL1B, CXCL1, STAT4, CCL2, TNF
NETPATH IL 1 PATHWAY UPRHOB, BIRC3, MMP14, JUN, CXCL1, CCL2, IL6, PTGS2, IL1B, AMPD3, CXCL2
NETPATH IL 4 PATHWAY UPFGL2, MXD1, REL, JUN, IBRDC3, PSCD1, CCL2, MAF, IL1RN, IL6, PTGER2, RIPK2, CD86, UPP1
NCI IL12 2PATHWAYSTAT1, IL12B, GADD45B, LCK, STAT4, GADD45G, IL1B, RIPK2
NCI IL6 7PATHWAYSTAT1, IL6, JUN, JUNB, IRF1, HCK
NETPATH IL 7 PATHWAY UPFAS, CXCL1, JUN, CCL5, CD86, CXCL2
GERY CEBP TARGETSGADD45B, HMOX1, CXCL1, EREG, HSPA1B, JUNB, DDIT3, GLA, GADD45G, CD47, ATF3, IFRD1
ST TUMOR NECROSIS FACTOR PATHWAYBIRC3, TNFAIP3, JUN, NFKB2, TNFRSF1B, TNF
NETPATH IL 4 PATHWAY DOWNSTAT1, UBE2L6, GADD45B, CCL2, TNFSF10, GBP2, TLR3, GEM, PTGS2, LY96, CXCL2, IRF1, MX1
NETPATH IL 3 PATHWAY UPIL1B, CCL2, CD86
NETPATH IL 6 PATHWAY UPSTAT1, GADD45B, CXCL1, JUN, JUNB, MAP3K8, NEU3, NMI, IRF1, PRDM1, MX1, TNF
NETPATH IL 5 PATHWAY UPPLSCR1, REL, BIRC3, TLR1, CCL2, TBK1, IL1B, UPP1, PRDM1, CASP4, IER3
WEINMANN ADAPTATION TO HYPOXIA UP
BIOCARTA IL10 PATHWAY
NCI BCR 5PATHWAY
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
NETPATH IL 9 PATHWAY UP
BIOCARTA NFKB PATHWAY
MAHAJAN RESPONSE TO IL1A UP
WEINMANN ADAPTATION TO HYPOXIA DN
KEGG GRAFT VERSUS HOST DISEASE
VARELA ZMPSTE24 TARGETS UP
NCI TNFPATHWAY
LINDSTEDT DENDRITIC CELL MATURATION B
BIOCARTA IL1R PATHWAY
KRASNOSELSKAYA ILF3 TARGETS UP
NCI HOST INTERACTIONS OF HIV FACTORS
RASHI RESPONSE TO IONIZING RADIATION 2
RADAEVA RESPONSE TO IFNA1 UP
LIEN BREAST CARCINOMA METAPLASTIC VS DUCTAL UP
AMIT EGF RESPONSE 40 HELA
BOWIE RESPONSE TO EXTRACELLULAR MATRIX
MITSIADES RESPONSE TO APLIDIN UP
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
MARTORIATI MDM4 TARGETS FETAL LIVER UP
BOYAULT LIVER CANCER SUBCLASS G56 DN
HINATA NFKB TARGETS KERATINOCYTE UP
RUTELLA RESPONSE TO CSF2RB AND IL4 UP
KOKKINAKIS METHIONINE DEPRIVATION 96HR UP
MARKEY RB1 ACUTE LOF UP
XU AKT1 TARGETS 6HR
KANG DOXORUBICIN RESISTANCE UP
COULOUARN TEMPORAL TGFB1 SIGNATURE UP
LIU VAV3 PROSTATE CARCINOGENESIS UP
REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES
SEITZ NEOPLASTIC TRANSFORMATION BY 8P DELETION UP
SHIPP DLBCL VS FOLLICULAR LYMPHOMA UP
DAUER STAT3 TARGETS DN
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 DN
AMIT EGF RESPONSE 120 HELA
DANG REGULATED BY MYC DN
MCLACHLAN DENTAL CARIES UP
IIZUKA LIVER CANCER PROGRESSION G1 G2 UP
PODAR RESPONSE TO ADAPHOSTIN UP
KYNG DNA DAMAGE UP
LEE LIVER CANCER E2F1 UP
KERLEY RESPONSE TO CISPLATIN UP
HELLER SILENCED BY METHYLATION UP
BOWIE RESPONSE TO TAMOXIFEN
GOZGIT ESR1 TARGETS DN
ICHIBA GRAFT VERSUS HOST DISEASE 35D UP
SMID BREAST CANCER LUMINAL B DN
ZHOU INFLAMMATORY RESPONSE LPS UP
FURUKAWA DUSP6 TARGETS PCI35 UP
NETPATH IL 3 PATHWAY DOWN
REACTOME TOLL LIKE RECEPTOR 4 CASCADE
VERHAAK AML WITH NPM1 MUTATED UP
BROCKE APOPTOSIS REVERSED BY IL6
REACTOME G ALPHA I SIGNALLING EVENTS
EGUCHI CELL CYCLE RB1 TARGETS
TIAN TNF SIGNALING VIA NFKB
HUMMEL BURKITTS LYMPHOMA DN
KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY
NCI VIF MEDIATED DEGRADATION OF APOBEC3G
WONG IFNA2 RESISTANCE UP
KEGG APOPTOSIS
CORUM NFKB1-NFKB2-REL-RELA-RELB COMPLEX
NCI DEGRADATION OF BETA CATENIN BY THE DESTRUCTION COMPLEX
CHIANG LIVER CANCER SUBCLASS CTNNB1 DN
HINATA NFKB TARGETS FIBROBLAST UP
CHARAFE BREAST CANCER LUMINAL VS BASAL DN
MISSIAGLIA REGULATED BY METHYLATION UP
NCI ATF2 PATHWAY
GEORGANTAS HSC MARKERS
KEGG PRIMARY IMMUNODEFICIENCY
ZHANG INTERFERON RESPONSE
CHANG IMMORTALIZED BY HPV31 DN
KYNG ENVIRONMENTAL STRESS RESPONSE NOT BY GAMMA IN OLD
CROONQUIST STROMAL STIMULATION UP
KHETCHOUMIAN TRIM24 TARGETS UP
KIM LRRC3B TARGETS
DACOSTA ERCC3 ALLELE XPCS VS TTD UP
HORIUCHI WTAP TARGETS UP
CORUM PA28-20S PROTEASOMEPSMA6, PSME2, PSME1
ZHANG ANTIVIRAL RESPONSE TO RIBAVIRIN UP
RUTELLA RESPONSE TO CSF2RB AND IL4 DN
BIOCARTA SODD PATHWAY
BIOCARTA TH1TH2 PATHWAY
CROONQUIST NRAS SIGNALING DN
TSAI DNAJB4 TARGETS UP
MORI PRE BI LYMPHOCYTE DN
DER IFN BETA RESPONSE UP
DEBIASI APOPTOSIS BY REOVIRUS INFECTION UP
NETPATH IL 6 PATHWAY
GALI TP53 TARGETS APOPTOTIC UP
BASSO CD40 SIGNALING UP
TIAN TNF SIGNALING NOT VIA NFKB
NAGASHIMA NRG1 SIGNALING UP
MARZEC IL2 SIGNALING UP
BIOCARTA BLYMPHOCYTE PATHWAY
ZERBINI RESPONSE TO SULINDAC UP
CROMER TUMORIGENESIS UP
FRIDMAN SENESCENCE UP
WU HBX TARGETS 2 DN
MAHADEVAN RESPONSE TO MP470 UP
SMID BREAST CANCER NORMAL LIKE UP
FERRARI RESPONSE TO FENRETINIDE UP
BIOCARTA TID PATHWAY
SANA RESPONSE TO IFNG UP
ZHANG ANTIVIRAL RESPONSE TO RIBAVIRIN DN
REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G
KEGG LEISHMANIA INFECTION
REACTOME COSTIMULATION BY THE CD28 FAMILY
ELVIDGE HIF1A AND HIF2A TARGETS DN
BOYLAN MULTIPLE MYELOMA PCA1 UP
CHEN HOXA5 TARGETS 9HR UP
KANNAN TP53 TARGETS UP
SEKI INFLAMMATORY RESPONSE LPS UP
GRAHAM CML QUIESCENT VS CML DIVIDING UP
CONCANNON APOPTOSIS BY EPOXOMICIN UP
MOSERLE IFNA RESPONSE
FOSTER INFLAMMATORY RESPONSE LPS UP
BIOCARTA ASBCELL PATHWAY
ODONNELL TARGETS OF MYC AND TFRC UP
CROONQUIST IL6 DEPRIVATION DN
KEGG CYTOSOLIC DNA SENSING PATHWAY
LINDSTEDT DENDRITIC CELL MATURATION C
REACTOME ACTIVATED TLR4 SIGNALLING
HESS TARGETS OF HOXA9 AND MEIS1 DN
ELVIDGE HYPOXIA BY DMOG UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
BERTUCCI MEDULLARY VS DUCTAL BREAST CANCER UP
NCI UBIQUITIN MEDIATED DEGRADATION OF PHOSPHORYLATED CDC25A
NCI ACTIVATION OF PRO CASPASE 8
RUTELLA RESPONSE TO HGF UP
HOSHIDA LIVER CANCER LATE RECURRENCE UP
PRAMOONJAGO SOX4 TARGETS UP
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA DN
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 1
ELVIDGE HIF1A TARGETS DN
REACTOME PD1 SIGNALING
BIOCARTA PML PATHWAY
GRAHAM CML DIVIDING VS NORMAL QUIESCENT UP
BIOCARTA NO2IL12 PATHWAY
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 16D UP
ICHIBA GRAFT VERSUS HOST DISEASE D7 UP
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING DN
LINDSTEDT DENDRITIC CELL MATURATION A
ELVIDGE HYPOXIA UP
BIOCARTA NKT PATHWAY
BROWNE INTERFERON RESPONSIVE GENES
REACTOME SIGNALING IN IMMUNE SYSTEM
ROETH TERT TARGETS UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION SUSTAINDED IN ERYTHROCYTE UP
ST TYPE I INTERFERON PATHWAY
FRIDMAN IMMORTALIZATION DN
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
VART KSHV INFECTION ANGIOGENIC MARKERS UP
NUYTTEN EZH2 TARGETS UP
DUTTA APOPTOSIS VIA NFKB
BIOCARTA IL22BP PATHWAY
DIRMEIER LMP1 RESPONSE EARLY
DER IFN GAMMA RESPONSE UP
KEGG INTESTINAL IMMUNE NETWORK FOR IGA PRODUCTION
NCI VPU MEDIATED DEGRADATION OF CD4
KYNG ENVIRONMENTAL STRESS RESPONSE UP
BENNETT SYSTEMIC LUPUS ERYTHEMATOSUS
ZHOU INFLAMMATORY RESPONSE LIVE UP
ONDER CDH1 TARGETS 3 DN
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 UP
NAKAYAMA SOFT TISSUE TUMORS PCA1 UP
LIAN LIPA TARGETS 6M
NIELSEN MALIGNAT FIBROUS HISTIOCYTOMA UP
WINTER HYPOXIA METAGENE
NEWMAN ERCC6 TARGETS UP
CORUM TNF-ALPHA/NF-KAPPA B SIGNALING COMPLEX CHUK KPNA3 NFKB2 NFKBIB REL IKBKG NFKB1 NFKBIE RELB NFKBIA RELA TNIP2
FOSTER INFLAMMATORY RESPONSE LPS DN
GAURNIER PSMD4 TARGETS
REACTOME P53 INDEPENDENT DNA DAMAGE RESPONSE
FARMER BREAST CANCER CLUSTER 1
GRANDVAUX IFN RESPONSE NOT VIA IRF3
SATO SILENCED BY DEACETYLATION IN PANCREATIC CANCER
NETPATH TNF ALPHA PATHWAY UP
MARKEY RB1 CHRONIC LOF DN
GESERICK TERT TARGETS DN
NOJIMA SFRP2 TARGETS DN
AMIT SERUM RESPONSE 120 MCF10A
TAVOR CEBPA TARGETS DN
REACTOME REGULATION OF ORNITHINE DECARBOXYLASE
LEE LIVER CANCER MYC E2F1 UP
SESTO RESPONSE TO UV C3
REACTOME DEATH RECEPTOR SIGNALLING
GEISS RESPONSE TO DSRNA UP
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 1
BOYLAN MULTIPLE MYELOMA C CLUSTER DN
ZHOU INFLAMMATORY RESPONSE FIMA UP
ROSTY CERVICAL CANCER PROLIFERATION CLUSTER
GRANDVAUX IRF3 TARGETS UP
ZHU CMV ALL UP
GRUETZMANN PANCREATIC CANCER UP
NCI SCF BETA TRCP MEDIATED DEGRADATION OF EMI1
KEGG PROTEASOME
NCI REGULATION OF ACTIVATED PAK 2P34 BY PROTEASOME MEDIATED DEGRADATION1
OKUMURA INFLAMMATORY RESPONSE LPS
NATSUME RESPONSE TO INTERFERON BETA UP
LEE LIVER CANCER HEPATOBLAST
NAGASHIMA EGF SIGNALING UP
AMIT DELAYED EARLY GENES
KEGG TYPE I DIABETES MELLITUS
AMIT EGF RESPONSE 60 MCF10A
KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION
NOJIMA SFRP2 TARGETS UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER UP
LEONARD HYPOXIA
WHITEFORD PEDIATRIC CANCER MARKERS
LEE LIVER CANCER MYC TGFA UP
BECKER TAMOXIFEN RESISTANCE UP
LEE LIVER CANCER DENA UP
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 9
WALLACE PROSTATE CANCER RACE UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D UP
WIELAND UP BY HBV INFECTION
COATES MACROPHAGE M1 VS M2 DN
ONDER CDH1 SIGNALING VIA CTNNB1
GUTIERREZ WALDENSTROEMS MACROGLOBULINEMIA 1 DN
ZHONG RESPONSE TO AZACITIDINE AND TSA UP
MAHADEVAN RESPONSE TO MP470 DN
UROSEVIC RESPONSE TO IMIQUIMOD
TSAI RESPONSE TO RADIATION THERAPY
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 3D UP
HARRIS HYPOXIA
NETPATH KIT RECEPTOR PATHWAY UP
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS DN
KOKKINAKIS METHIONINE DEPRIVATION 48HR UP
RUGO ENVIRONMENTAL STRESS RESPONSE UP
SOUCEK MYC TARGETS
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 6HR DN
IZADPANAH STEM CELL ADIPOSE VS BONE UP
ZHAN MULTIPLE MYELOMA LB DN
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION HSC UP
KEGG AUTOIMMUNE THYROID DISEASE
FLECHNER BIOPSY KIDNEY TRANSPLANT REJECTED VS OK UP
SHAFFER IRF4 MULTIPLE MYELOMA PROGRAM
BILD HRAS ONCOGENIC SIGNATURE
LIANG SILENCED BY METHYLATION 2
DAUER STAT3 TARGETS UP
DER IFN ALPHA RESPONSE UP
LEE LIVER CANCER ACOX1 UP
CORUM INTERFERON-STIMULATED GENE FACTOR 3 TRANSCRIPTION COMPLEX ISGF3
BIOCARTA GSK3 PATHWAY
PELLICCIOTTA HDAC IN ANTIGEN PRESENTATION DN
EINAV INTERFERON SIGNATURE IN CANCER
DAZARD UV RESPONSE CLUSTER G2
NCI CD40 PATHWAY
MCLACHLAN DENTAL CARIES DN
LEI MYB TARGETS
KEGG ALLOGRAFT REJECTION
AMIT SERUM RESPONSE 40 MCF10A
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
ZHU CMV 8 HR UP
GAUSSMANN MLL AF4 FUSION TARGETS F UP
SANA TNF SIGNALING UP
BIOCARTA INFLAM PATHWAY
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 8D UP
SENESE HDAC1 AND HDAC2 TARGETS UP
NCI IL27PATHWAY
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 3D DN
XU HGF TARGETS INDUCED BY AKT1 6HR
ONDER CDH1 TARGETS 2 DN
NAKAJIMA MAST CELL
REACTOME STABILIZATION OF P53
NCI REGULATION OF ORNITHINE DECARBOXYLASE ODC
MAINA VHL TARGETS DN
CASTELLANO NRAS TARGETS UP
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 2
KEGG HEMATOPOIETIC CELL LINEAGE
LIAN LIPA TARGETS 3M
KEGG CHEMOKINE SIGNALING PATHWAY
FUJII YBX1 TARGETS UP
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
JISON SICKLE CELL DISEASE UP
NCI IL12 STAT4PATHWAY
BIOCARTA CTLA4 PATHWAY
XU HGF SIGNALING NOT VIA AKT1 48HR UP
DASU IL6 SIGNALING UP
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
ZHAN MULTIPLE MYELOMA HP UP
NCI REGULATION OF ACTIVATED PAK 2P34 BY PROTEASOME MEDIATED DEGRADATION
ZUCCHI METASTASIS DN
LU IL4 SIGNALING
KEGG ANTIGEN PROCESSING AND PRESENTATION
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
ehrlichia chaffeensis arkansabifidobacterium bifidummycobacterium tuberculosisGeneSet Name
0.00029 0.07512 0.00008NETPATH_IL_2_PATHWAY_UP
0.00000 0.00000 0.00126NCI_IL23PATHWAY
0.00744 0.00007 0.00602NETPATH_IL_1_PATHWAY_UP
0.00011 0.05727 0.01106NETPATH_IL_4_PATHWAY_UP
0.00000 0.00033 0.00051NCI_IL12_2PATHWAY
0.00000 0.08284 0.00288NCI_IL6_7PATHWAY
0.00034 0.01764 0.00856NETPATH_IL_7_PATHWAY_UP
0.01308 0.00008 0.00000GERY_CEBP_TARGETS
0.00584 0.00028 0.00010ST_TUMOR_NECROSIS_FACTOR_PATHWAY
0.00001 0.00103 0.00000NETPATH_IL_4_PATHWAY_DOWN
0.00000 0.01084 0.00171NETPATH_IL_3_PATHWAY_UP
0.00003 0.00007 0.00000NETPATH_IL_6_PATHWAY_UP
0.00007 0.11144 0.00000NETPATH_IL_5_PATHWAY_UP
0.07131 0.11428 0.14894WEINMANN_ADAPTATION_TO_HYPOXIA_UP
0.00082 0.00000 0.00336BIOCARTA_IL10_PATHWAY
0.06932 0.19352 0.00144NCI_BCR_5PATHWAY
0.00021 0.00214 0.00002GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.00097 0.00572 0.08229NETPATH_IL_9_PATHWAY_UP
0.06659 0.00950 0.00073BIOCARTA_NFKB_PATHWAY
0.01198 0.00474 0.00132MAHAJAN_RESPONSE_TO_IL1A_UP
0.01089 0.01898 0.03354WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.00000 0.00101 0.02321KEGG_GRAFT_VERSUS_HOST_DISEASE
0.05834 0.07949 0.00035VARELA_ZMPSTE24_TARGETS_UP
0.16521 0.00099 0.01252NCI_TNFPATHWAY
0.00007 0.00000 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.17481 0.01532 0.00118BIOCARTA_IL1R_PATHWAY
0.00016 0.13661 0.00000KRASNOSELSKAYA_ILF3_TARGETS_UP
0.03268 0.04307 0.00787NCI_HOST_INTERACTIONS_OF_HIV_FACTORS
0.00307 0.00098 0.00000RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.00000 0.00000 0.00000RADAEVA_RESPONSE_TO_IFNA1_UP
0.03933 0.06739 0.00196LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.03874 0.00190 0.00000AMIT_EGF_RESPONSE_40_HELA
0.00254 0.00216 0.00000BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX
0.09988 0.13478 0.00000MITSIADES_RESPONSE_TO_APLIDIN_UP
0.01384 0.07330 0.00000THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.00081 0.00139 0.00000TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.19874 0.17120 0.05130MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
0.00017 0.16391 0.07983BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN
0.00055 0.00013 0.00000HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.08512 0.10892 0.00000RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
0.03945 0.06502 0.02144KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
0.00000 0.00000 0.00000MARKEY_RB1_ACUTE_LOF_UP
0.00698 0.00292 0.00000XU_AKT1_TARGETS_6HR
0.00467 0.00000 0.00000KANG_DOXORUBICIN_RESISTANCE_UP
0.11433 0.02296 0.02560COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP
0.00000 0.10808 0.00067LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
0.00000 0.00006 0.00176REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES
0.00001 0.00442 0.00000SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP
0.16678 0.00000 0.09738SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP
0.00007 0.00000 0.00000DAUER_STAT3_TARGETS_DN
0.00181 0.17262 0.00116RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
0.07404 0.00402 0.00000AMIT_EGF_RESPONSE_120_HELA
0.00130 0.10901 0.00880DANG_REGULATED_BY_MYC_DN
0.00000 0.00155 0.00000MCLACHLAN_DENTAL_CARIES_UP
0.05216 0.02644 0.00171IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP
0.00428 0.00133 0.00000PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.00021 0.14393 0.00460KYNG_DNA_DAMAGE_UP
0.00000 0.00724 0.00014LEE_LIVER_CANCER_E2F1_UP
0.06718 0.03252 0.04549KERLEY_RESPONSE_TO_CISPLATIN_UP
0.00000 0.02743 0.00000HELLER_SILENCED_BY_METHYLATION_UP
0.00015 0.00013 0.00000BOWIE_RESPONSE_TO_TAMOXIFEN
0.11644 0.14873 0.00047GOZGIT_ESR1_TARGETS_DN
0.00000 0.00865 0.00021ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
0.00000 0.13028 0.07952SMID_BREAST_CANCER_LUMINAL_B_DN
0.00269 0.00000 0.00000ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.07466 0.05128 0.00001FURUKAWA_DUSP6_TARGETS_PCI35_UP
0.01795 0.07891 0.09475NETPATH_IL_3_PATHWAY_DOWN
0.00013 0.08044 0.10884REACTOME_TOLL_LIKE_RECEPTOR_4_CASCADE
0.00000 0.02011 0.00000VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.00000 0.02793 0.00000BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.00009 0.09003 0.10331REACTOME_G_ALPHA_I_SIGNALLING_EVENTS
0.15675 0.00000 0.00000EGUCHI_CELL_CYCLE_RB1_TARGETS
0.00003 0.00000 0.00000TIAN_TNF_SIGNALING_VIA_NFKB
0.00212 0.06060 0.00035HUMMEL_BURKITTS_LYMPHOMA_DN
0.00000 0.00000 0.00000KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.07820 0.07191 0.00789NCI_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G
0.16431 0.07560 0.12549WONG_IFNA2_RESISTANCE_UP
0.04003 0.11172 0.16900KEGG_APOPTOSIS
0.16701 0.17640 0.05523CORUM_NFKB1-NFKB2-REL-RELA-RELB_COMPLEX
0.10740 0.04509 0.00348NCI_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX
0.00033 0.05799 0.00205CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
0.00358 0.05376 0.00000HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.00013 0.01383 0.00002CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
0.00123 0.00000 0.00000MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.02314 0.19891 0.06127NCI_ATF2_PATHWAY
0.01658 0.08067 0.00021GEORGANTAS_HSC_MARKERS
0.00075 0.17981 0.03373KEGG_PRIMARY_IMMUNODEFICIENCY
0.00000 0.00000 0.00000ZHANG_INTERFERON_RESPONSE
0.00135 0.08520 0.00000CHANG_IMMORTALIZED_BY_HPV31_DN
0.16497 0.09807 0.02501KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD
0.00000 0.01386 0.00025CROONQUIST_STROMAL_STIMULATION_UP
0.00000 0.07904 0.00000KHETCHOUMIAN_TRIM24_TARGETS_UP
0.00000 0.00007 0.00000KIM_LRRC3B_TARGETS
0.11533 0.10436 0.08089DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP
0.00147 0.00296 0.00000HORIUCHI_WTAP_TARGETS_UP
0.00680 0.08416 0.01169CORUM_PA28-20S_PROTEASOME
0.03161 0.00489 0.00000ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP
0.00000 0.10663 0.00000RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
0.14474 0.01392 0.10024BIOCARTA_SODD_PATHWAY
0.00111 0.00394 0.13686BIOCARTA_TH1TH2_PATHWAY
0.02002 0.00000 0.00000CROONQUIST_NRAS_SIGNALING_DN
0.01306 0.02695 0.00004TSAI_DNAJB4_TARGETS_UP
0.00013 0.17576 0.00014MORI_PRE_BI_LYMPHOCYTE_DN
0.00030 0.02261 0.00000DER_IFN_BETA_RESPONSE_UP
0.00144 0.04303 0.00000DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.17299 0.11299 0.04845NETPATH_IL_6_PATHWAY
0.05198 0.03207 0.17731GALI_TP53_TARGETS_APOPTOTIC_UP
0.00000 0.00006 0.00000BASSO_CD40_SIGNALING_UP
0.09628 0.06403 0.00011TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.00648 0.05507 0.00000NAGASHIMA_NRG1_SIGNALING_UP
0.00161 0.02397 0.00127MARZEC_IL2_SIGNALING_UP
0.00871 0.04026 0.04300BIOCARTA_BLYMPHOCYTE_PATHWAY
0.07345 0.11328 0.04554ZERBINI_RESPONSE_TO_SULINDAC_UP
0.12793 0.07318 0.01999CROMER_TUMORIGENESIS_UP
0.00696 0.13001 0.00067FRIDMAN_SENESCENCE_UP
0.02731 0.10021 0.10873WU_HBX_TARGETS_2_DN
0.00029 0.00318 0.00004MAHADEVAN_RESPONSE_TO_MP470_UP
0.00000 0.17152 0.15473SMID_BREAST_CANCER_NORMAL_LIKE_UP
0.00947 0.05329 0.00018FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.01590 0.06186 0.01104BIOCARTA_TID_PATHWAY
0.00000 0.00000 0.00000SANA_RESPONSE_TO_IFNG_UP
0.06898 0.05362 0.00534ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
0.06904 0.14766 0.00468REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G
0.00000 0.00573 0.00007KEGG_LEISHMANIA_INFECTION
0.00274 0.01543 0.01228REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY
0.06645 0.13514 0.04633ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
0.00000 0.11977 0.07526BOYLAN_MULTIPLE_MYELOMA_PCA1_UP
0.01709 0.07447 0.00006CHEN_HOXA5_TARGETS_9HR_UP
0.12522 0.14881 0.10269KANNAN_TP53_TARGETS_UP
0.00000 0.00000 0.00000SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.00007 0.00000 0.00000GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.06066 0.00015 0.00028CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
0.00000 0.00000 0.00000MOSERLE_IFNA_RESPONSE
0.00000 0.00000 0.00000FOSTER_INFLAMMATORY_RESPONSE_LPS_UP
0.00639 0.00436 0.10630BIOCARTA_ASBCELL_PATHWAY
0.00039 0.10487 0.00736ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
0.00700 0.00000 0.00000CROONQUIST_IL6_DEPRIVATION_DN
0.01044 0.00006 0.00059KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.11079 0.05251 0.15036LINDSTEDT_DENDRITIC_CELL_MATURATION_C
0.00561 0.13698 0.14568REACTOME_ACTIVATED_TLR4_SIGNALLING
0.00000 0.09533 0.00000HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.04510 0.00784 0.00043ELVIDGE_HYPOXIA_BY_DMOG_UP
0.00511 0.01525 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.00000 0.11780 0.00002BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
0.04449 0.04750 0.01224NCI_UBIQUITIN_MEDIATED_DEGRADATION_OF_PHOSPHORYLATED_CDC25A
0.03577 0.00481 0.04958NCI_ACTIVATION_OF_PRO_CASPASE_8
0.01712 0.05087 0.00000RUTELLA_RESPONSE_TO_HGF_UP
0.00000 0.13571 0.07998HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP
0.07569 0.00000 0.00000PRAMOONJAGO_SOX4_TARGETS_UP
0.05114 0.00605 0.00000PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.18992 0.11573 0.03057YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
0.08874 0.07855 0.04594ELVIDGE_HIF1A_TARGETS_DN
0.00177 0.14938 0.00266REACTOME_PD1_SIGNALING
0.01308 0.04511 0.02320BIOCARTA_PML_PATHWAY
0.01356 0.00000 0.00000GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP
0.00012 0.03249 0.09603BIOCARTA_NO2IL12_PATHWAY
0.00000 0.00117 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
0.00000 0.00000 0.00000ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.00068 0.00000 0.00000GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN
0.00000 0.00005 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.01170 0.02232 0.00052ELVIDGE_HYPOXIA_UP
0.00005 0.03302 0.00137BIOCARTA_NKT_PATHWAY
0.00000 0.00000 0.00000BROWNE_INTERFERON_RESPONSIVE_GENES
0.00000 0.15636 0.00051REACTOME_SIGNALING_IN_IMMUNE_SYSTEM
0.01826 0.00294 0.00015ROETH_TERT_TARGETS_UP
0.04656 0.02138 0.00199TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.00856 0.08675 0.06313ST_TYPE_I_INTERFERON_PATHWAY
0.01489 0.04157 0.00089FRIDMAN_IMMORTALIZATION_DN
0.00013 0.00000 0.00060KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.02454 0.00397 0.01566VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
0.00475 0.00779 0.00000NUYTTEN_EZH2_TARGETS_UP
0.00000 0.00215 0.00002DUTTA_APOPTOSIS_VIA_NFKB
0.01255 0.00102 0.01147BIOCARTA_IL22BP_PATHWAY
0.00000 0.00294 0.00000DIRMEIER_LMP1_RESPONSE_EARLY
0.00007 0.00551 0.00000DER_IFN_GAMMA_RESPONSE_UP
0.00899 0.00179 0.00469KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION
0.07748 0.04727 0.00707NCI_VPU_MEDIATED_DEGRADATION_OF_CD4
0.05113 0.05265 0.00275KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP
0.00000 0.00000 0.00000BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.01092 0.00000 0.00002ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.02809 0.01033 0.10086ONDER_CDH1_TARGETS_3_DN
0.00123 0.08197 0.00000RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
0.00000 0.13644 0.00000NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
0.00000 0.04912 0.00002LIAN_LIPA_TARGETS_6M
0.01021 0.04736 0.02002NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.11984 0.01386 0.00019WINTER_HYPOXIA_METAGENE
0.00936 0.19779 0.00177NEWMAN_ERCC6_TARGETS_UP
0.13511 0.00667 0.00136CORUM_TNF-ALPHA/NF-KAPPA_B_SIGNALING_COMPLEX_CHUK_KPNA3_NFKB2_NFKBIB_REL_IKBKG__NFKB1_NFKBIE_RELB__NFKBIA_RELA_TNIP2
0.00000 0.00000 0.00000FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.00000 0.00007 0.00000GAURNIER_PSMD4_TARGETS
0.03913 0.11407 0.01493REACTOME_P53_INDEPENDENT_DNA_DAMAGE_RESPONSE
0.00000 0.00019 0.00000FARMER_BREAST_CANCER_CLUSTER_1
0.00010 0.00064 0.00000GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3
0.02810 0.02093 0.00117SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.04059 0.11156 0.00534NETPATH_TNF_ALPHA_PATHWAY_UP
0.00000 0.07695 0.01556MARKEY_RB1_CHRONIC_LOF_DN
0.00047 0.05480 0.00002GESERICK_TERT_TARGETS_DN
0.00573 0.05582 0.00051NOJIMA_SFRP2_TARGETS_DN
0.04018 0.07807 0.00013AMIT_SERUM_RESPONSE_120_MCF10A
0.00058 0.05786 0.00294TAVOR_CEBPA_TARGETS_DN
0.02844 0.10685 0.02161REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE
0.00000 0.02392 0.00022LEE_LIVER_CANCER_MYC_E2F1_UP
0.17152 0.00136 0.00000SESTO_RESPONSE_TO_UV_C3
0.02731 0.00063 0.01374REACTOME_DEATH_RECEPTOR_SIGNALLING
0.00175 0.00426 0.00000GEISS_RESPONSE_TO_DSRNA_UP
0.00015 0.00145 0.00000GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.00221 0.14936 0.00666SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
0.07185 0.05463 0.04451BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN
0.09979 0.00015 0.00047ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
0.00053 0.00000 0.00000ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER
0.00446 0.02965 0.00065GRANDVAUX_IRF3_TARGETS_UP
0.00053 0.03180 0.00000ZHU_CMV_ALL_UP
0.00043 0.12988 0.00008GRUETZMANN_PANCREATIC_CANCER_UP
0.07201 0.04677 0.00570NCI_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1
0.03642 0.19567 0.00367KEGG_PROTEASOME
0.02845 0.06494 0.00809NCI_REGULATION_OF_ACTIVATED_PAK_2P34_BY_PROTEASOME_MEDIATED_DEGRADATION1
0.16268 0.17661 0.04117OKUMURA_INFLAMMATORY_RESPONSE_LPS
0.09234 0.06876 0.00485NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
0.00021 0.02142 0.13990LEE_LIVER_CANCER_HEPATOBLAST
0.00040 0.09324 0.00000NAGASHIMA_EGF_SIGNALING_UP
0.11440 0.02649 0.00001AMIT_DELAYED_EARLY_GENES
0.00153 0.00021 0.06667KEGG_TYPE_I_DIABETES_MELLITUS
0.02646 0.00467 0.00004AMIT_EGF_RESPONSE_60_MCF10A
0.00000 0.00000 0.00225KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.01772 0.00005 0.00000NOJIMA_SFRP2_TARGETS_UP
0.00488 0.01391 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.00021 0.08510 0.00000SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.01232 0.00822 0.01105LEONARD_HYPOXIA
0.18032 0.00000 0.00000WHITEFORD_PEDIATRIC_CANCER_MARKERS
0.00006 0.13364 0.00029LEE_LIVER_CANCER_MYC_TGFA_UP
0.07948 0.15774 0.00573BECKER_TAMOXIFEN_RESISTANCE_UP
0.00000 0.06650 0.01367LEE_LIVER_CANCER_DENA_UP
0.01067 0.05595 0.00294YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9
0.00000 0.00167 0.00000WALLACE_PROSTATE_CANCER_RACE_UP
0.00001 0.00005 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
0.00000 0.02002 0.00000WIELAND_UP_BY_HBV_INFECTION
0.00007 0.06575 0.02011COATES_MACROPHAGE_M1_VS_M2_DN
0.05380 0.13470 0.01211ONDER_CDH1_SIGNALING_VIA_CTNNB1
0.15904 0.02725 0.01382GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN
0.06062 0.05098 0.01736ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
0.18500 0.00016 0.00000MAHADEVAN_RESPONSE_TO_MP470_DN
0.00000 0.00005 0.00000UROSEVIC_RESPONSE_TO_IMIQUIMOD
0.02983 0.00063 0.00000TSAI_RESPONSE_TO_RADIATION_THERAPY
0.00000 0.00000 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.00160 0.05400 0.00067HARRIS_HYPOXIA
0.02531 0.08735 0.00019NETPATH_KIT_RECEPTOR_PATHWAY_UP
0.00000 0.00457 0.00000FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
0.01570 0.11437 0.00022KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
0.06675 0.03196 0.00227RUGO_ENVIRONMENTAL_STRESS_RESPONSE_UP
0.00003 0.00012 0.02521SOUCEK_MYC_TARGETS
0.17707 0.00389 0.00228TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.00277 0.10012 0.00047IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
0.00000 0.01616 0.00000ZHAN_MULTIPLE_MYELOMA_LB_DN
0.01161 0.06300 0.00137TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
0.01760 0.00055 0.00343KEGG_AUTOIMMUNE_THYROID_DISEASE
0.00000 0.18711 0.00012FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.14892 0.00315 0.00240SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM
0.00696 0.00118 0.00000BILD_HRAS_ONCOGENIC_SIGNATURE
0.00001 0.00000 0.00000LIANG_SILENCED_BY_METHYLATION_2
0.01097 0.00011 0.00000DAUER_STAT3_TARGETS_UP
0.00000 0.00081 0.00000DER_IFN_ALPHA_RESPONSE_UP
0.00152 0.00208 0.00473LEE_LIVER_CANCER_ACOX1_UP
0.10550 0.15530 0.13577CORUM_INTERFERON-STIMULATED_GENE_FACTOR_3_TRANSCRIPTION_COMPLEX_ISGF3
0.07399 0.16284 0.02075BIOCARTA_GSK3_PATHWAY
0.02780 0.11301 0.00008PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN
0.00023 0.00000 0.00000EINAV_INTERFERON_SIGNATURE_IN_CANCER
0.03944 0.03296 0.01541DAZARD_UV_RESPONSE_CLUSTER_G2
0.08348 0.01529 0.01575NCI_CD40_PATHWAY
0.00000 0.00444 0.00001MCLACHLAN_DENTAL_CARIES_DN
0.06393 0.13824 0.10821LEI_MYB_TARGETS
0.00009 0.00011 0.00549KEGG_ALLOGRAFT_REJECTION
0.00705 0.01845 0.00000AMIT_SERUM_RESPONSE_40_MCF10A
0.00000 0.00000 0.00000ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.00000 0.00006 0.00000ZHU_CMV_8_HR_UP
0.13801 0.16417 0.00215GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP
0.00000 0.00000 0.00000SANA_TNF_SIGNALING_UP
0.03146 0.00002 0.05068BIOCARTA_INFLAM_PATHWAY
0.00104 0.00019 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP
0.15854 0.19319 0.01303SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.00000 0.00000 0.04359NCI_IL27PATHWAY
0.00030 0.02366 0.00300TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN
0.03408 0.04693 0.00001XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR
0.00757 0.09938 0.00500ONDER_CDH1_TARGETS_2_DN
0.01857 0.01389 0.04663NAKAJIMA_MAST_CELL
0.05325 0.15123 0.00975REACTOME_STABILIZATION_OF_P53
0.01628 0.04850 0.02665NCI_REGULATION_OF_ORNITHINE_DECARBOXYLASE__ODC_
0.08042 0.16459 0.00177MAINA_VHL_TARGETS_DN
0.00014 0.00034 0.00316CASTELLANO_NRAS_TARGETS_UP
0.00262 0.02116 0.00000HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.00029 0.00313 0.04041SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
0.00000 0.03856 0.11260KEGG_HEMATOPOIETIC_CELL_LINEAGE
0.00000 0.05374 0.00000LIAN_LIPA_TARGETS_3M
0.00000 0.10844 0.02902KEGG_CHEMOKINE_SIGNALING_PATHWAY
0.00177 0.00024 0.01288FUJII_YBX1_TARGETS_UP
0.02814 0.08234 0.00000UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.00000 0.00331 0.00000JISON_SICKLE_CELL_DISEASE_UP
0.00000 0.06861 0.13077NCI_IL12_STAT4PATHWAY
0.01304 0.00424 0.02940BIOCARTA_CTLA4_PATHWAY
0.00356 0.10586 0.00469XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
0.14492 0.05109 0.00006DASU_IL6_SIGNALING_UP
0.00001 0.00000 0.00002GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.01306 0.11568 0.00952ZHAN_MULTIPLE_MYELOMA_HP_UP
0.02962 0.04561 0.00636NCI_REGULATION_OF_ACTIVATED_PAK_2P34_BY_PROTEASOME_MEDIATED_DEGRADATION
0.10538 0.03751 0.00039ZUCCHI_METASTASIS_DN
0.00276 0.01831 0.02153LU_IL4_SIGNALING
0.02449 0.02975 0.00022KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION